Literature DB >> 28603554

Botulism mortality in the USA, 1975-2009.

Kelly A Jackson1, Barbara E Mahon1, John Copeland2, Ryan P Fagan1.   

Abstract

Botulism had mortality rates >60% before the 1950s. We reviewed confirmed botulism cases in the USA during 1975-2009 including infant, foodborne, wound, and other/unknown acquisition categories, and calculated mortality ratios. We created a multivariate logistic regression model for non-infant cases (foodborne, wound, and other/unknown). Overall mortality was 3.0% with 109 botulism-related deaths among 3,618 botulism cases [18 (<1%) deaths among 2,352 infant botulism cases, 61 (7.1%) deaths among 854 foodborne botulism cases, 18 (5.0%) deaths among 359 wound botulism cases, and 12 (22.6%) deaths among 53 other/unknown botulism cases]. Mortality among all cases increased with age; it was lowest among infants (0.8%) and highest among persons ≥80 years old (34.4%). Toxin type F had higher mortality (13.8%) than types A, B, or E (range, 1.4% to 4.1%). Efforts to reduce botulism mortality should target non-infant transmission categories and older adults.

Entities:  

Keywords:  USA; age groups; botulism; food; infant; mortality

Year:  2016        PMID: 28603554      PMCID: PMC5460764          DOI: 10.1504/TBJ.2015.078132

Source DB:  PubMed          Journal:  Botulinum J        ISSN: 1754-7318


  18 in total

1.  Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-03-19       Impact factor: 17.586

2.  Rapid detection of foodborne botulism outbreaks facilitated by epidemiological linking of cases: implications for food defense and public health response.

Authors:  Ryan W Newkirk; Craig W Hedberg
Journal:  Foodborne Pathog Dis       Date:  2012-02       Impact factor: 3.171

3.  History of technology in the intensive care unit.

Authors:  Nitin Puri; Vinod Puri; R P Dellinger
Journal:  Crit Care Clin       Date:  2009-01       Impact factor: 3.598

4.  Adult botulism type F in the United States, 1981-2002.

Authors:  A Gupta; C J Sumner; M Castor; S Maslanka; J Sobel
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

5.  Botulism from chopped garlic: delayed recognition of a major outbreak.

Authors:  M E St Louis; S H Peck; D Bowering; G B Morgan; J Blatherwick; S Banerjee; G D Kettyls; W A Black; M E Milling; A H Hauschild
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

6.  Wound botulism in California, 1951-1998: recent epidemic in heroin injectors.

Authors:  S B Werner; D Passaro; J McGee; R Schechter; D J Vugia
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

7.  Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin.

Authors:  Ryan P Fagan; Karen P Neil; Randy Sasich; Carolina Luquez; Hakam Asaad; Susan Maslanka; Wajahat Khalil
Journal:  Clin Infect Dis       Date:  2011-09-06       Impact factor: 9.079

8.  Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988.

Authors:  B A Woodruff; P M Griffin; L M McCroskey; J F Smart; R B Wainwright; R G Bryant; L C Hutwagner; C L Hatheway
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

9.  Foodborne botulism in the United States, 1990-2000.

Authors:  Jeremy Sobel; Nicole Tucker; Alana Sulka; Joseph McLaughlin; Susan Maslanka
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

10.  Asymmetric type F botulism with cranial nerve demyelination.

Authors:  Alina Filozov; Jessica A Kattan; Lavanya Jitendranath; C Gregory Smith; Carolina Lúquez; Quyen N Phan; Ryan P Fagan
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

View more
  10 in total

1.  Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA").

Authors:  Sabine Pellett; William H Tepp; Guangyun Lin; Eric A Johnson
Journal:  Toxicon       Date:  2017-12-19       Impact factor: 3.033

2.  Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin.

Authors:  Patricia A Yu; Neal H Lin; Barbara E Mahon; Jeremy Sobel; Yon Yu; Rajal K Mody; Weidong Gu; Jennifer Clements; Hye-Joo Kim; Agam K Rao
Journal:  Clin Infect Dis       Date:  2017-12-27       Impact factor: 9.079

3.  A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979-2019.

Authors:  Richard Harris; Christine Tchao; Natalie Prystajecky; Jennifer Cutler; John W Austin
Journal:  Can Commun Dis Rep       Date:  2021-06-08

4.  Use of Crystallography and Molecular Modeling for the Inhibition of the Botulinum Neurotoxin A Protease.

Authors:  Lewis D Turner; Alexander L Nielsen; Lucy Lin; Antonio J Campedelli; Nicholas R Silvaggi; Jason S Chen; Amanda E Wakefield; Karen N Allen; Kim D Janda
Journal:  ACS Med Chem Lett       Date:  2021-07-28       Impact factor: 4.632

5.  A Case Report of Wound Botulism - Rare Disease on the Rise with the Opioid Crisis.

Authors:  Miki Kiyokawa; Haning Haning
Journal:  Hawaii J Health Soc Welf       Date:  2021-02-01

Review 6.  Botulinum Neurotoxin Detection Methods for Public Health Response and Surveillance.

Authors:  Nagarajan Thirunavukkarasu; Eric Johnson; Segaran Pillai; David Hodge; Larry Stanker; Travis Wentz; BalRam Singh; Kodumudi Venkateswaran; Patrick McNutt; Michael Adler; Eric Brown; Thomas Hammack; Donald Burr; Shashi Sharma
Journal:  Front Bioeng Biotechnol       Date:  2018-06-22

Review 7.  Vaccine Production to Protect Animals Against Pathogenic Clostridia.

Authors:  Nicolas E Zaragoza; Camila A Orellana; Glenn A Moonen; George Moutafis; Esteban Marcellin
Journal:  Toxins (Basel)       Date:  2019-09-11       Impact factor: 4.546

Review 8.  Foodborne botulism: A brief review of cases transmitted by cheese products (Review).

Authors:  Elias Chaidoutis; Dimitrios Keramydas; Petros Papalexis; Athanasios Migdanis; Ioannis Migdanis; Andreas Ch Lazaris; Nikolaos Kavantzas
Journal:  Biomed Rep       Date:  2022-03-15

9.  Irreversible inhibition of BoNT/A protease: proximity-driven reactivity contingent upon a bifunctional approach.

Authors:  Lewis D Turner; Alexander L Nielsen; Lucy Lin; Sabine Pellett; Takashi Sugane; Margaret E Olson; Eric A Johnson; Kim D Janda
Journal:  RSC Med Chem       Date:  2021-05-19

10.  Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B.

Authors:  J T Guptill; S M Raja; V C Juel; E B Walter; M Cohen-Wolkowiez; H Hill; E Sendra; B Hauser; P Jackson; G K Swamy
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.